collect
vulner
threat
emerg
microbi
pathogen
remain
disturbingli
evid
enter
twentyfi
rst
centuri
despit
two
centuri
knowledg
germ
theori
diseas
break
genet
code
sequenc
genom
virtual
everi
major
bacteri
viral
pathogen
capabl
caus
diseas
humankind
still
fi
nd
suscept
infecti
diseas
dens
concentr
citi
interconnect
human
societi
link
intern
aviat
put
us
continu
risk
futur
epidem
inevit
occur
ever
expand
popul
growth
speci
forc
environment
chang
ventur
spars
inhabit
rainforest
popul
remot
ecosystem
cultiv
natur
habitat
support
voraci
human
appetit
good
servic
global
warm
environment
degrad
land
develop
along
human
upheav
natur
calam
creat
new
outbreak
novel
pathogen
renew
spread
ancient
scourg
like
cholera
plagu
numer
exampl
intercontinent
spread
microbi
pathogen
within
last
fi
year
alon
give
notic
suscept
human
popul
emerg
infecti
diseas
tabl
perhap
best
exemplifi
ed
tragic
event
set
motion
late
previous
unidentifi
ed
obscur
anim
coronaviru
known
sever
acut
respiratori
syndrom
sar
cov
fi
rst
introduc
unsuspect
human
popul
southern
china
current
molecular
evid
indic
food
handler
exot
food
wet
market
guangdong
provinc
probabl
fi
rst
becam
infect
anim
coronaviru
civet
cat
newli
deriv
anim
viru
adapt
infect
human
effi
cientli
spread
persontoperson
infect
aerosol
ill
chines
physician
affect
region
travel
hong
kong
attend
wed
spend
singl
night
amoy
garden
hotel
citi
infect
individu
appear
spread
viru
least
hotel
guest
next
sever
day
peopl
return
home
fi
differ
countri
incub
sarscov
pathogen
respiratori
secret
next
month
newli
acquir
coronaviru
spread
countri
worldwid
caus
case
sar
result
nearli
death
earli
global
effort
larg
number
dilig
public
health
offi
cial
laboratori
scientist
outbreak
end
within
year
yet
seen
except
occasion
laboratoryacquir
accid
divers
array
pathogen
produc
recent
outbreak
concern
vulner
pathogen
within
global
villag
occupi
share
fl
ora
fauna
microorgan
tabl
spread
mosquito
avian
infl
uenza
infl
uenza
h
n
risk
pandem
infl
uenza
sporad
human
case
avian
fl
u
asia
mortal
rate
sever
acut
sar
associ
coronaviru
risk
spread
zoonot
respiratori
syndrom
virus
outbreak
sar
southern
china
worldwid
epidem
case
death
monkey
pox
orthopox
viru
risk
exot
pet
trade
outbreak
wild
rodent
human
midwestern
usa
sale
gambian
giant
rat
africa
west
nile
viru
mosquitoborn
fl
aviviru
risk
intern
spread
wnv
wnv
africa
new
york
thousand
case
hundr
death
north
america
next
year
inhal
anthrax
intent
releas
vulner
bacillu
anthraci
spore
bioterror
case
usa
mail
system
oseltamivirresist
infl
uenza
gene
commun
azoleresist
outbreak
occur
candida
spp
born
west
nile
viru
north
america
prionrel
foodborn
variant
creutzfeldtjakob
diseas
hemorrhag
fever
virus
constant
remind
suscept
pathogen
natur
resid
anim
speci
omnipres
fear
next
pandem
infl
uenza
heighten
recent
evolutionari
chang
virul
transmiss
avian
fl
u
virus
standard
chemotherapeut
regimen
infecti
diseas
may
reliabl
rescu
person
sever
infect
new
millennium
commun
nosocomi
outbreak
multidrug
resist
pathogen
evidenc
methicillin
vancomycin
resist
staphylococcu
aureu
resist
new
antivir
neuraminidas
inhibitor
recent
infl
uenza
isol
caus
real
concern
care
hospit
critic
ill
patient
like
fundament
chang
current
trend
progress
emerg
antimicrobi
resist
commonli
prescrib
antibiot
signifi
cantli
alter
near
futur
regrett
littl
evid
situat
like
chang
unless
concert
effort
taken
sever
front
revers
current
trajectori
increas
antibiot
resist
fi
tness
microorgan
depend
upon
capac
genet
adapt
rapidli
chang
environment
condit
antimicrobi
agent
exert
strong
select
pressur
microbi
popul
favor
organ
capabl
resist
genet
variabl
may
occur
varieti
mechan
point
mutat
may
occur
nucleotid
base
pair
refer
microevolutionari
chang
mutat
may
alter
target
site
antimicrobi
agent
alter
inhibitori
capac
point
mutat
insid
adjac
activ
site
exist
betalactamas
gene
eg
gene
gener
remark
array
newli
recogn
extendedspectrum
betalactamas
betalactam
antibiot
known
almost
year
widespread
use
creat
select
pressur
bacteri
pathogen
resist
inhibitori
action
least
differ
bacteri
enzym
character
hydrolyz
betalactam
antibiot
hydrolyz
enzym
exist
four
basic
molecular
class
classifi
ed
list
tabl
enzym
either
serin
hydrolas
class
c
zinc
contain
metalloenzym
zincbind
thiol
group
activ
site
class
b
enzym
microevolutionari
event
account
differenti
activ
array
betalactamas
care
studi
bacteri
enzym
even
internet
websit
devot
specifi
calli
molecular
properti
http
wwwlaheyorgstudieswebthtm
betalactamas
activ
becom
ubiquit
among
bacteri
popul
prompt
develop
specifi
c
betalactamas
inhibitor
compound
clavulan
tazobactam
sulbactam
effort
combat
common
bacteri
resist
mechan
counter
gener
inhibitor
betalactamas
inhibitor
multidrugresist
bacteria
ongo
confl
ict
pathogen
chemotherapeut
strategi
erad
microorgan
recent
demonstr
least
bacteri
popul
capac
increas
mutat
rate
time
environment
stress
exposur
antibiot
stress
respons
known
so
respons
transient
hypermut
highli
advantag
organ
increas
rate
genet
variat
time
unfavor
environment
condit
possibl
bacteria
upregul
pace
evolut
attempt
develop
clone
resist
action
antibiot
dna
polymeras
organ
reduc
fi
deliti
replic
subsequ
increas
rate
mutat
occurr
result
excess
nucleotid
mispair
recombin
system
bacteria
reca
system
becom
less
restrict
degre
homolog
dna
sequenc
crossov
event
permit
occur
fl
urri
mutat
event
occur
stress
bacteria
fi
nal
attempt
gener
resist
subpopul
bacteria
presenc
environment
challeng
presenc
new
antibiot
process
even
phenotyp
link
alter
growth
rate
biofi
lm
format
strain
pseudomona
aeruginosa
second
level
genom
variabl
bacteria
refer
macroevolutionari
chang
result
wholescal
rearrang
larg
segment
dna
singl
event
rearrang
may
includ
invers
duplica
tion
insert
delet
transposit
larg
sequenc
dna
one
locat
bacteri
chromosom
plasmid
anoth
wholescal
rearrang
larg
segment
bacteri
genom
frequent
creat
special
genet
element
known
transposon
insert
sequenc
capac
move
independ
unit
rest
bacteri
genom
acquisit
foreign
dna
sequenc
extracellular
environ
may
taken
natur
compet
bacteria
eg
streptococci
neisseri
organ
transform
sequenc
becom
integr
host
genom
homolog
sequenc
gener
recombin
dna
repair
system
bacteria
inherit
foreign
dna
element
contribut
organ
abil
cope
select
pressur
impos
upon
antimicrobi
agent
third
level
genet
variabl
bacteria
creat
acquisit
foreign
dna
carri
plasmid
bacteriophag
extrachromosom
dna
element
provid
readi
access
dispos
yet
potenti
highli
advantag
gene
includ
antibiot
resist
gene
plasmid
phage
particl
element
autonom
selfrepl
remain
unattach
cytoplasm
bacteri
cell
integr
directli
chromosom
bacteri
host
capac
replic
move
independ
chromosom
ad
variabl
entir
bacteri
genom
dna
evid
whole
genom
sequenc
project
indic
genom
rearrang
bacteriophag
sequenc
insert
sequenc
commonplac
bacteri
chromosom
genet
variat
provid
bacteria
seemingli
limitless
system
alter
genom
rapidli
evolv
develop
resist
virtual
antimicrobi
agent
recent
exampl
vancomycinresist
enterococci
aureu
extend
spectrum
betalactamas
carbapenemas
product
transfer
quinolon
resist
p
aeruginosa
enterobacteria
attest
capac
microorgan
adapt
environment
stress
induc
antibiot
exposur
virus
fungi
also
quit
capabl
rapid
antimicrobi
resist
develop
resist
capac
pose
addit
threat
manag
icu
patient
seriou
infect
varieti
potenti
pathogen
antibiot
resist
gene
probabl
aros
detoxifi
enzym
synthet
enzym
alter
substrat
specifi
citi
critic
mutat
recombin
event
result
format
mosaic
gene
entir
new
function
alter
penicillin
bind
protein
mediat
betalactam
resist
multipl
bacteri
genera
eg
methicillinresist
aureu
mrsa
penicillinresist
streptococci
pneumococci
chromosom
resist
gonococci
may
evolv
gene
fusion
penicillin
bind
protein
involv
bacteri
cell
wall
synthesi
anoth
common
resist
strategi
chang
regul
metabol
activ
enzym
system
affect
antibiot
increas
rate
folat
precursor
synthesi
exampl
overcom
inhibitor
effect
sulfa
drug
trimethoprim
mani
common
antibiot
resist
gene
accident
acquir
stolen
antibiot
produc
bacteria
streptomyc
relat
soil
bacteria
sourc
mani
standard
antimicrobi
agent
use
clinic
medicin
today
bacteria
coevolv
capac
synthes
antibiot
along
necessari
resist
gene
protect
metabol
machineri
antibiot
produc
resist
gene
antibiot
produc
bacteria
provid
readi
genet
blueprint
resist
target
antibiot
suscept
bacteria
acquir
resist
gene
recent
evid
confi
rming
inde
occur
found
yokoyama
colleagu
japan
investig
sudden
outbreak
p
aeruginosa
highlevel
resist
essenti
clinic
avail
aminoglycosid
investig
discov
resist
strain
acquir
new
methylas
gene
block
bind
site
inhibit
aminoglycosid
specifi
c
sequenc
ribosom
rna
ident
mechan
highli
homolog
gene
found
aminoglycosideproduc
strain
streptomyc
relat
bacteria
least
seven
distinct
mechan
antibiot
resist
describ
bacteria
summar
tabl
detoxifi
enzym
use
degrad
betalactam
modifi
aminoglycosid
longer
enter
bacteri
membran
attach
ribosom
target
enzym
identifi
ed
inhibit
aminoglycosid
one
three
gener
reaction
nacetyl
onucleotidyl
ophosphoryl
detoxifi
enzym
also
one
resist
mechan
chloramphenicol
rare
util
certain
bacteri
strain
inactiv
macrolid
lincosamid
tetracyclin
streptogramin
recogn
earli
histori
antibiot
develop
penicillin
effect
gramposit
bacteria
gramneg
bacteria
differ
suscept
penicillin
due
larg
part
outer
membran
lipid
bilay
act
barrier
penetr
antibiot
cell
situat
outsid
peptidoglycan
cell
wall
gramneg
bacteria
outer
membran
absent
gramposit
bacteria
outer
portion
lipid
bilay
compos
princip
lipopolysaccharid
lp
made
tightli
bound
hydrocarbon
molecul
imped
entri
hydrophob
antibiot
penicillin
macrolid
passag
hydrophil
antibiot
outer
membran
facilit
presenc
porin
protein
arrang
form
waterfi
lled
diffus
channel
antibiot
may
travers
bacteria
usual
produc
larg
number
porin
differ
physiochem
properti
permeabl
characterist
size
approxim
porin
molecul
cell
escherichia
coli
bacteria
abl
regul
rel
number
differ
porin
respons
osmolar
microenviron
hyperosmolar
condit
e
coli
repress
synthesi
larger
porin
ompf
continu
express
smaller
one
ompc
mutat
result
loss
specifi
c
porin
occur
clinic
isol
determin
increas
resist
betalactam
antibiot
resist
aminoglycosid
carbapenem
emerg
therapi
also
associ
lack
product
outer
membran
protein
p
aeruginosa
resist
imipenem
appear
due
interact
chromosom
betalactamas
activ
loss
specifi
c
entri
channel
porin
rate
entri
aminoglycosid
molecul
bacteri
cell
function
bind
usual
nonsatur
anion
transport
whereupon
retain
posit
charg
subsequ
pull
across
cytoplasm
membran
intern
neg
charg
cell
process
requir
energi
threshold
level
intern
neg
charg
signifi
cant
transport
occur
proton
motiv
forc
aminoglycosideresist
isol
alter
proton
motiv
forc
may
occur
longterm
aminoglycosid
therapi
isol
usual
small
coloni
phenotyp
due
reduc
rate
growth
im
gramneg
gramneg
bacteria
tmp
trimethoprim
tcn
tetracyclin
common
mechan
common
less
common
report
see
refer
activ
effl
ux
antimicrobi
agent
increasingli
util
bacteria
fungi
mechan
antibiot
resist
strain
e
coli
shigella
enter
organ
express
membran
transport
system
lead
multidrug
resist
drug
effl
ux
specifi
c
effl
ux
pump
also
exist
promot
egress
singl
class
antimicrobi
agent
effl
ux
mechan
major
mechan
resist
tetracyclin
gramneg
bacteria
strain
pneumonia
pyogen
aureu
epidermidi
use
activ
effl
ux
mechan
resist
macrolid
streptogramin
azalid
effl
ux
mechan
mediat
mef
macrolid
effl
ux
gene
streptococci
msr
macrolid
streptogramin
resist
gene
staphylococci
similar
effl
ux
system
encod
gene
refer
mrea
macrolid
resist
effl
ux
describ
group
b
streptococci
mechan
resist
may
preval
communityacquir
infect
gener
appreci
dissemin
resist
gene
among
import
bacteri
pathogen
constitut
major
threat
continu
use
macrolid
antibiot
activ
effl
ux
mechan
may
also
contribut
full
express
betalactam
resist
p
aeruginosa
multidrug
effl
ux
pump
inner
outer
membran
p
aeruginosa
may
combin
periplasm
betalactamas
membran
permeabl
compon
full
express
antibiot
resist
activ
effl
ux
fl
uoroquinolon
specifi
c
quinolon
pump
multidrug
transport
pump
also
detect
enter
bacteria
staphylococci
resist
wide
varieti
antimicrobi
agent
includ
tetracyclin
macrolid
lincosamid
streptogramin
aminoglycosid
may
result
alter
ribosom
bind
site
ml
b
determin
gene
produc
enzym
dimethyl
adenin
residu
ribosom
rna
subunit
prokaryot
ribosom
disrupt
bind
drug
ribosom
resist
aminoglycosid
may
also
mediat
ribosom
level
mutat
protein
subunit
shown
interfer
bind
streptomycin
ribosom
ribosom
resist
streptomycin
may
signifi
cant
caus
streptomycin
resist
among
enterococc
isol
ribosom
resist
aminoglycosid
gentamicin
tobramycin
amikacin
appear
uncommon
may
requir
multipl
mutat
aminoglycosid
bind
sever
site
subunit
ribosom
vancomycin
glycopeptid
antibiot
teicoplanin
bind
dalaninedalanin
present
termini
peptidoglycan
precursor
larg
glycopeptid
molecul
prevent
incorpor
precursor
cell
wall
resist
enterococci
vancomycin
classifi
ed
ag
base
upon
genotyp
type
target
site
modifi
cation
level
resist
vancomycin
teicoplanin
strain
e
faecium
e
faecali
highlevel
resist
vancomycin
teicoplanin
class
resist
class
resist
mediat
vana
gene
cluster
found
r
plasmid
protein
synthes
peptidoglycan
precursor
depsipeptid
terminu
dalaninedlact
instead
usual
dalaninedalanin
modifi
peptidoglycan
bind
glycopeptid
antibiot
reduc
affi
niti
thu
confer
resist
vancomycin
teicoplanin
class
vancomycin
resist
gene
vari
level
resist
speci
distribut
specifi
c
cell
wall
alter
vancomycinintermedi
strain
resist
aureu
visa
isol
heterogen
resist
pattern
visa
strain
express
unusu
thick
peptidoglycan
cell
wall
less
complet
crosslink
togeth
cell
wall
strain
visa
contain
nonamid
glutamin
precursor
provid
increas
number
fals
bind
site
vancomycin
vancomycin
molecul
absorb
excess
bind
site
therebi
reduc
vancomycin
concentr
growth
point
peptidoglycan
synthesi
along
inner
surfac
cell
wall
arriv
high
level
vancomycin
resist
vana
express
aureu
creat
renew
sens
urgenc
need
develop
novel
strategi
combat
multidrug
resist
bacteri
pathogen
betalactam
antibiot
inhibit
bacteria
bind
coval
penicillinbind
protein
pbp
cytoplasm
membran
target
protein
catalyz
synthesi
peptidoglycan
form
cell
wall
bacteria
gramposit
bacteria
resist
betalactam
antibiot
may
occur
decreas
affi
niti
pbp
antibiot
chang
amount
pbp
produc
bacterium
low
affi
niti
bind
pbp
may
induc
product
stimul
exposur
microorgan
betalactam
drug
structur
gene
meca
determin
lowaffi
niti
pbp
mrsa
share
extens
sequenc
homolog
pbp
e
coli
gene
regul
product
lowaffi
niti
pbp
consider
sequenc
homolog
gene
regul
product
staphylococc
penicillinas
pbp
betalactamaseneg
penicillinresist
strain
n
gonorrhoea
n
meningitidi
haemophilu
infl
uenza
shown
reduc
penicillinbind
affi
niti
pbp
appear
encod
hybrid
gene
contain
segment
dna
scaveng
resist
strain
relat
speci
similar
penicillinresist
pneumococci
dna
gyras
also
known
bacteri
topoisomeras
ii
necessari
supercoil
chromosom
dna
bacteria
order
effi
cient
cell
divis
anoth
relat
enzym
topoisomeras
iv
also
requir
segreg
bacteri
genom
two
daughter
cell
cell
divis
enzym
consist
two
subunit
encod
gyra
gene
two
b
subunit
encod
gyrb
gene
parc
pare
topoisomeras
iv
although
spontan
mutat
ot
asubunit
gyra
locu
common
caus
resist
multipl
fl
uoroquinolon
enter
bacteria
bsubunit
alter
may
also
affect
resist
drug
dna
gyras
topoisomeras
ii
primari
site
action
gramneg
bacteria
wherea
topoisomeras
iv
princip
target
quinolon
gramposit
bacteria
mutat
varieti
chromosom
loci
describ
result
alter
dna
gyras
resist
nalidix
acid
newer
fl
uoroquinolon
enterobacteriacea
p
aeruginosa
mani
mutat
involv
substitut
singl
amino
acid
key
enzymat
site
locat
amino
acid
gyras
subunit
involv
gener
dna
gyrasebacteri
dna
complex
two
common
gene
mediat
resist
sulfa
drug
wide
varieti
pathogen
bacteria
known
gene
give
rise
alter
form
target
enzym
sulfonamid
dihydroptero
synthas
dhp
alter
dhp
enzym
mediat
sulfonamid
resist
gene
longer
bind
sulfa
yet
continu
synthes
dihydroptero
paraaminobenzo
acid
substrat
trimethoprim
potent
inhibitor
bacteri
dihydrofol
reductas
dhfr
larg
number
alter
dhfr
enzym
loss
inhibit
trimethoprim
describ
gene
found
primarili
r
plasmid
alter
dhfr
gene
widespread
gramneg
bacteria
also
found
staphylococci
dfra
gene
tetracyclin
resist
may
mediat
mechan
interfer
abil
tetracyclin
bind
ribosom
ubiquit
tetm
resist
gene
relat
tetracyclin
resist
determin
protect
ribosom
tetracyclin
action
tetm
gene
gener
protein
elong
factorlik
activ
may
stabil
ribosom
transfer
rna
interact
presenc
tetracyclin
molecul
sulfonamid
compet
paraaminobenzo
acid
bind
enzym
dihydroptero
synthas
therebi
block
folic
acid
synthesi
necessari
nucleic
acid
synthesi
sulfonamid
resist
may
mediat
bacteria
product
synthet
enzym
dihydroptero
synthas
gene
respons
dhp
felp
strain
bacteria
produc
excess
dhp
overwhelm
sulfa
inhibit
trimethoprim
resist
may
also
occur
similar
fashion
make
excess
amount
dihydrofol
reductas
bacteri
chromosom
gene
fola
unusu
mechan
resist
specifi
c
antibiot
develop
auxotroph
specifi
c
growth
factor
requir
seen
wildtyp
strain
mutant
requir
substrat
normal
synthes
target
enzym
thu
substrat
present
environ
organ
abl
grow
despit
inhibit
synthet
enzym
antibiot
bacteria
lose
enzym
thymidyl
synthetas
thymin
depend
acquir
exogen
suppli
thymidin
synthes
thymidyl
via
salvag
pathway
host
highli
resist
sulfa
drug
trimethoprim
antibiot
resist
gene
evolv
resist
determin
dissemin
among
bacteri
popul
transform
transduct
conjug
transposit
favor
clone
bacteria
prolifer
fl
ora
patient
receiv
antibiot
antibioticresist
gene
found
among
bacteria
even
preantibiot
therapi
era
howev
select
pressur
place
upon
microbi
popul
highli
lethal
antimicrobi
compound
creat
environ
individu
clone
resist
antibiot
markedli
favor
resist
popul
prolifer
rapidli
replac
suscept
strain
bacteria
antibiot
resist
gene
place
metabol
cost
bacteria
mani
microorgan
evolv
strategi
limit
cost
limit
express
altern
gene
product
phase
variat
mechan
allow
favor
sometim
costli
gene
mediat
antibiot
resist
persist
absenc
continu
antibiot
select
pressur
yet
rapidli
express
upon
reexposur
antibiot
plasmid
particularli
well
adapt
serv
agent
genet
evolut
rgene
dissemin
plasmid
extrachromosom
genet
element
made
circular
doublestrand
dna
molecul
rang
less
greater
kilobas
pair
extrem
common
clinic
isol
bacteri
pathogen
although
multipl
copi
specifi
c
plasmid
multipl
differ
plasmid
may
found
singl
bacteri
cell
close
relat
plasmid
often
coexist
cell
observ
led
classifi
cation
scheme
plasmid
base
upon
incompat
group
plasmid
may
determin
wide
rang
function
besid
antibiot
resist
includ
virul
metabol
capac
plasmid
autonom
selfrepl
genet
element
possess
origin
replic
gene
facilit
stabl
mainten
host
bacteria
conjug
plasmid
requir
addit
gene
initi
selftransf
transfer
plasmid
dna
bacteri
speci
complex
process
thu
conjug
plasmid
tend
larger
nonconjug
one
small
plasmid
may
abl
util
conjug
apparatu
coresid
conjug
plasmid
mani
plasmidencod
function
enabl
bacteri
strain
persist
environ
resist
noxiou
agent
heavi
metal
mercuri
releas
dental
fi
lling
may
increas
number
antibioticresist
bacteria
oral
fl
ora
hexachlorophen
topic
bacteriostat
agent
environ
may
actual
promot
plasmidmedi
resist
agent
antimicrobi
agent
transposon
special
sequenc
dna
mobil
transloc
unit
one
area
bacteri
chromosom
anoth
also
move
back
forth
chromosom
plasmid
bacteriophag
dna
transpos
genet
element
possess
special
system
recombin
independ
gener
recombin
system
permit
recombin
larg
homolog
sequenc
dna
crossov
event
reca
system
bacteria
recaindepend
recombin
system
transposas
transpos
element
usual
occur
random
fashion
nonhomolog
dna
sequenc
result
wholescal
modifi
cation
larg
sequenc
dna
singl
event
two
type
transpos
genet
element
transposon
insert
sequenc
mobil
sequenc
probabl
play
import
physiolog
role
genet
variat
evolut
prokaryot
organ
transposon
differ
insert
sequenc
mediat
recogniz
phenotyp
marker
antibioticresist
trait
either
element
transloc
independ
unit
element
fl
ank
either
end
short
ident
sequenc
dna
revers
order
invert
repeat
invertedrepeat
dna
termini
essenti
transposit
process
transposon
insert
sequenc
must
physic
integr
chromosom
bacteriophag
plasmid
dna
order
replic
maintain
bacteri
popul
transposon
capabl
move
one
bacterium
anoth
without
transfer
within
plasmid
bacteriophag
conjug
transposon
found
primarili
aerob
anaerob
gramposit
organ
rapidli
effi
cientli
spread
antibiot
resist
gene
transposit
like
point
mutat
continu
ongo
process
bacteri
popul
transposon
also
essenti
evolut
r
plasmid
contain
multipl
antibioticresist
determin
highlevel
vancomycin
resist
vana
enterococci
mediat
composit
transposon
encod
seri
gene
need
express
vancomycin
resist
singl
transposon
may
encod
multipl
antibioticresist
determin
within
invertedrepeat
termini
well
genet
exchang
antibioticresist
gene
occur
bacteria
wide
dispar
speci
differ
genera
ident
aminoglycosideresist
gene
spread
gramneg
gramposit
bacteria
aerob
anaerob
bacteria
given
highli
variabl
environment
select
pressur
creat
wide
varieti
antibiot
plastic
bacteri
genom
ongo
evolut
multidrug
resist
bacteri
organ
probabl
inevit
structur
gene
mediat
antibiot
resist
often
close
link
may
exist
tandem
along
bacteri
chromosom
plasmid
genet
analysi
sequenc
dna
adjac
resist
gene
identifi
ed
uniqu
integr
unit
near
promot
site
integr
region
known
integron
function
conveni
recombin
hot
spot
sitespecifi
c
recombin
event
larg
nonhomolog
sequenc
dna
integron
provid
integras
function
common
attach
integr
site
acquisit
foreign
dna
sequenc
integron
widespread
bacteri
popul
provid
conveni
site
insert
multipl
differ
resist
gene
foreign
dna
sourc
four
class
integron
type
integron
common
pathogen
microorgan
integron
also
serv
effi
cient
express
cassett
resist
gene
integron
possess
promot
site
close
proxim
newli
insert
dna
sequenc
numer
cluster
differ
resist
gene
link
integron
specifi
c
insert
site
integron
may
mani
fi
resist
gene
link
sequenc
fl
ank
specifi
c
basepair
spacer
unit
integronmedi
multipl
resist
gene
cassett
fl
ank
transposon
mobil
plasmid
transfer
bacteri
speci
conjug
system
genet
exchang
widespread
dissemin
multipl
antibiot
resist
gene
accomplish
rapid
frighteningli
effi
cient
manner
time
concern
scientist
warn
possibl
widespread
antibiot
resist
lead
loss
effect
antibiot
clinic
medicin
warn
larg
ignor
assum
human
need
profi
motiv
free
enterpris
would
stimul
pharmaceut
compani
continu
develop
new
antibiot
could
discov
new
target
futur
antimicrobi
drug
may
possibl
keep
pace
even
exceed
rate
antibiot
resist
gene
develop
microbi
pathogen
number
disconcert
reason
human
may
lose
ground
rather
gain
pathogen
st
centuri
recent
survey
new
pharmaceut
product
found
fi
new
antibiot
new
molecular
entiti
research
develop
pipelin
pace
new
antibiot
discoveri
turn
trickl
dri
compar
even
year
ago
market
realiti
regrett
set
develop
new
antibiot
favor
lucr
option
greater
market
profi
drug
chronic
ill
less
risk
longer
revenu
stream
reimburs
return
invest
unfavor
antibiot
market
system
meet
need
societi
respect
new
antibiot
develop
far
reach
bold
initi
desper
need
crisi
loss
antibiot
effect
avoid
disincent
new
antibiot
develop
propos
solut
list
tabl
bacteri
strain
contain
complex
aggreg
gene
may
link
togeth
combat
inhibitori
effect
antibiot
sinc
prokaryot
organ
contribut
common
gene
pool
favor
gene
mediat
antibiot
resist
may
dissemin
among
bacteri
divers
microbi
genera
speci
increas
evid
multipl
antibiot
resist
mechan
within
bacterium
singl
type
antibiot
cooper
bacteri
popul
within
biofi
lm
attest
remark
ingenu
fl
exibl
bacteri
popul
thu
use
one
antibiot
may
select
emerg
resist
anoth
mobil
genet
element
rapidli
evolv
integron
cassett
multipl
antibiot
resist
gene
endow
bacteria
remark
capac
resist
antibiot
although
develop
antibiot
resist
may
inevit
rate
develop
reduc
ration
use
antibiot
use
centuri
diagnost
method
employ
realtim
pcr
genom
cultur
suscept
test
treat
proteom
identifi
pathogen
st
centuri
diseas
encourag
empir
resist
gene
target
treat
specifi
c
broadspectrum
antibiot
drug
use
infect
narrow
spectrum
drug
pcr
polymeras
chain
reaction
wider
access
molecular
techniqu
comput
technolog
rapidli
identifi
specifi
c
microorgan
resist
potenti
track
spread
patient
within
hospit
commun
consider
benefi
control
antibiot
resist
need
util
empir
broadspectrum
antibiot
day
even
week
sampl
sent
cultur
suscept
test
need
stop
need
specifi
c
inform
real
time
assur
patient
specifi
c
infect
treat
effect
narrowspectrum
drug
use
antibiot
nonmed
use
entir
ban
antibiot
use
today
nonmed
use
agricultur
food
prepar
industri
use
add
environment
contamin
low
level
antibiot
subinhibitori
concentr
antibiot
foster
develop
resist
clone
bacteria
caus
infect
human
use
nonantibiot
approach
manag
infecti
diseas
need
support
develop
use
plasmabas
antibodi
therapi
antibacteri
antivir
antifung
vaccin
encourag
futur
manag
common
invas
pathogen
staphylococc
infect
becom
complic
given
rapid
spread
simultan
betalactam
aminoglycosid
quinoloneresist
isol
recent
report
vancomycinresist
aureu
japan
unit
state
suggest
common
invas
microbi
pathogen
may
becom
refractori
chemotherapeut
agent
futur
new
drug
discoveri
allow
us
one
step
ahead
bacteri
pathogen
latter
half
twentieth
centuri
unlik
continu
record
remark
success
microbi
pathogen
new
millennium
rapid
evolut
resist
limit
durat
effect
antibiot
certain
pathogen
best
hope
futur
continu
develop
new
antibiot
strategi
order
retain
antimicrobi
activ
exist
new
antibiot
clinician
assist
care
antibiot
stewardship
tighten
infect
control
measur
antimicrobi
agent
substanti
impact
decreas
human
morbid
mortal
rate
serv
us
well
antimicrobi
era
behoov
us
improv
diagnost
surveil
effort
exercis
caution
administ
antibiot
maintain
continu
effi
caci
